Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neural Transm (Vienna). 2006 Oct;113(10):1435-9. Epub 2006 Feb 9.

The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.

Author information

  • 1Department of Neurology, Ajou University School of Medicine, Suwon, South Korea. phisland@chol.com

Abstract

alpha-Synuclein, a synaptic protein of unknown function, is a major component of Lewy bodies and may play a role in the pathophysiological process of Parkinson's disease (PD). In this study, we measured the plasma alpha-synuclein levels in 105 patients with PD, 38 patients with multiple system atrophy (MSA), and 51 age-matched controls. The alpha-synuclein level was significantly elevated in patients with PD (79.9 +/- 4.0 pg/ml, p < 0.001) and in those with MSA (78.1 +/- 3.5 pg/ml, p = 0.019) compared with the level in controls (76.1 +/- 3.9 pg/ml). The alpha-synuclein level was higher in patients with PD than in those with MSA (79.9 +/- 4.0 vs 78.1 +/- 3.5, p = 0.016). Our study demonstrated that the alpha-synuclein level in plasma is elevated in patients with PD and MSA.

PMID:
16465458
DOI:
10.1007/s00702-005-0427-9
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center